메뉴 건너뛰기




Volumn 21, Issue 20, 2011, Pages 6049-6053

Synthesis and biological evaluation of 1-substituted-3-(6-methylpyridin-2- yl)-4-([1,2,4triazolo[1,5-apyridin-6-yl)pyrazoles as transforming growth factor-β type 1 receptor kinase inhibitors

Author keywords

ALK5 inhibitor; Cancer; Cell based luciferase reporter assay; Fibrosis; Kinase assay; TGF

Indexed keywords

3 (6 METHYLPYRIDIN 2 YL) 4 ([1,2,4]TRIAZOLO[1,5 A]PYRIDIN 6 YL)PYRAZOLE DERIVATIVE; 4 ([1,2,4]TRIAZOLO[1,5 A]PYRIDIN 6 YL) N (4 METHOXYPHENYL) 3 (6 METHYLPYRIDIN 2 YL) 1H PYRAZOLE 1 CARBOTHIOAMIDE; PHOSPHOTRANSFERASE INHIBITOR; PYRAZOLE DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1 INHIBITOR; UNCLASSIFIED DRUG;

EID: 80052927702     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2011.08.064     Document Type: Article
Times cited : (39)

References (42)
  • 17
    • 80052947180 scopus 로고    scopus 로고
    • PCT Int. Appl. WO 2007018818 A1
    • Mundla, S. R. PCT Int. Appl. WO 2007018818 A1, 2007.
    • (2007)
    • Mundla, S.R.1
  • 35
    • 80052930602 scopus 로고    scopus 로고
    • J. PCT Int. Appl. WO 2004111046 A2
    • Dodic, N.; Donche, F.; Gellibert, F. J. PCT Int. Appl. WO 2004111046 A2, 2004.
    • (2004)
    • Dodic, N.1    Donche, F.2    Gellibert, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.